Infantile Fibrosarcoma | CHOP Research Institute
 

Infantile Fibrosarcoma

Published on
Dec 20, 2024
Congratulations to two CHOP physicians and researchers who were inducted as new fellows into the College of Physicians of Philadelphia.

The purpose of this study is to test the safety and efficacy of the investigational drug called repotrectinib in children whose cancers have specific genetic changes (in the ALK, ROS1, or NTRK1-3 genes).